Pulmonary arterial hypertension (PAH), also known as Group 1 Pulmonary Hypertension
(PH), is a PH subset characterized by pulmonary vascular remodeling and pulmonary …

Pulmonary arterial hypertension (PAH) is characterized by an important occlusive vascular
remodeling with the production of new endothelial cells, smooth muscle cells …

Background/Aims: Tanshinone IIA (Tan IIA) is effective in the treatment of inflammation and
atherosclerosis. The adhesion of inflammatory cells to vascular endothelium plays important …

Pulmonary hypertension (PH) is a progressive complex fatal disease of multiple etiologies.
Hyperproliferation and resistance to apoptosis of vascular cells of intimal, medial, and …

Background/Aims: Oxidized low-density lipoprotein (ox-LDL) is a major component of
hyperlipidemia and contributes to atherosclerosis. Endothelial progenitor cells (EPCs) play …

Pulmonary arterial hypertension (PAH) is a rare subtype of group 1 pulmonary hypertension
(PH) diseases, characterized by high pulmonary artery pressure leading to right ventricular …

Background Pulmonary arterial hypertension (PAH) is a pulmonary vascular disease with a
high mortality, characterized by typical angio-proliferative lesions. Erythropoietin (EPO) …

Background Pulmonary arterial hypertension (PAH) is a rare disease characterized by
widespread loss of the pulmonary microcirculation and elevated pulmonary arterial …

Myxomatous mitral valve disease (MMVD) stands out as the most prevalent acquired canine
heart disease. Its occurrence can reach up to 40% in small breed dogs and escalates in …

Background The purpose of this paper was to examine the effects of nicotinamide (ND) and l-
arginine (l-ARG) on pulmonary vascular and heart changes induced by pulmonary …